Related Experiment Video
Updated: Jun 8, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Microvascular dysfunction in chronic total coronary occlusions
G S Werner1, M Ferrari, B M Richartz
1Clinic for Internal Medicine III, Friedrich-Schiller-University Jena, Erlanger Allee 101, Jena, Germany. gerald.werner@med.uni-jena.de
Insights
Microvascular dysfunction affects over half of patients with chronic total coronary occlusions (TCOs), particularly those with diabetes or hypertension. Combining coronary flow velocity reserve (CFVR) and fractional flow reserve (FFR) is crucial for accurate assessment after TCO angioplasty.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Coronary Artery Disease
Background:
- Microvascular dysfunction is characterized by reduced coronary flow reserve without epicardial stenosis.
- This study investigated the prevalence and impact of microvascular dysfunction in chronic total coronary occlusions (TCOs).
Purpose of the Study:
- To determine the prevalence of microvascular dysfunction in TCOs.
- To assess the relationship between microvascular dysfunction and regional myocardial function.
- To evaluate the utility of coronary flow velocity reserve (CFVR) and fractional flow reserve (FFR) in TCOs.
Main Methods:
- Recanalization and stenting of TCOs in 42 patients.
- Coronary flow velocity reserve (CFVR) measured by intracoronary Doppler.
- Fractional flow reserve (FFR) recorded in a subset of 27 patients.
- CFVR reassessed after 24 hours in 21 patients.
Main Results:
- 55% of patients exhibited reduced CFVR (<2.0).
- In a subgroup, 52% showed reduced CFVR with a non-significant FFR (>=0.75), indicating microvascular dysfunction.
- Microvascular dysfunction was more prevalent in patients with diabetes and/or hypertension.
- CFVR and FFR were poorly correlated (r=0.03).
Conclusions:
- Microvascular dysfunction is common in TCOs (55%), irrespective of regional myocardial function.
- Diabetes and hypertension are associated with increased microvascular dysfunction.
- Neither CFVR nor FFR alone is sufficient for assessing angioplasty outcomes in TCOs; combined assessment is recommended.
Background:
Microvascular dysfunction is defined as reduced coronary flow reserve in the absence of an epicardial stenosis. This study determined its prevalence and relation to regional myocardial function in chronic total coronary occlusions (TCO).
Methods And Results:
After recanalization and stenting of a TCO (duration, >4 weeks) in 42 patients, coronary flow velocity reserve (CFVR) was measured by intracoronary Doppler. In a subset of 27 patients, intracoronary pressure was recorded to obtain the fractional flow reserve (FFR). In 21 patients, the CFVR was reassessed after 24 hours. CFVR was <2.0 in 55% of all patients. In the subgroup with simultaneous pressure recordings, 52% of patients showed a CFVR<2.0 and a FFR>/=0.75, indicating microvascular dysfunction. Both reduced CFVR and reduced FFR occurred in only 2 patients (7.7%). CFVR and FFR were not correlated (r=0.03). A low CFVR was associated with a higher baseline average peak velocity (35.6+/-16.6 versus 22.4+/-11.5 cm/s; P=0.006). Doppler parameters did not change within 24 hours. Regional dysfunction had no influence on CFVR. Patients with diabetes and/or hypertension had a lower CFVR than those without this comorbidity (1.86+/-0.69 versus 2.36+/-0.45; P<0.05).
Conclusions:
Microvascular dysfunction was observed in 55% of TCOs, independent of the impairment of regional myocardial function. Dysfunction was observed more often in patients with diabetes and hypertension. Neither CFVR or FFR alone is appropriate for assessing angioplasty results in patients with a TCO; CFVR should be combined with FFR to differentiate microvascular dysfunction from residual coronary stenosis or diffuse disease.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

